Compare ResMed Inc. (RMD) vs Banco Santander SA (SAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Banco Santander SA — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Banco Santander SA trades at $13.75 (market cap $191.46B). The key difference: Banco Santander SA is far larger — about 6.6× ResMed Inc.'s market cap, and Banco Santander SA pays the higher dividend (2.09%). Which is the better fit depends on your goals.
| RMD | SAN | |
|---|---|---|
Market Cap | $28.81B | $191.46B |
Sector | Health | Financials |
52-Week High | $293.73 | $14.37 |
52-Week Low | $182.82 | $8.40 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →
